Sunshine Biopharma (SBFM) FCF Margin Growth (3y) (2021 - 2026)
Sunshine Biopharma (SBFM) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 5,795.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,795.00 |
| Mar 31, 2026 | 1,212.00 |
| Dec 31, 2025 | 4,312.00 |
| Sep 30, 2025 | 83,832.00 |
| Jun 30, 2025 | 36,632.00 |
| Mar 31, 2025 | 104,427.00 |
| Dec 31, 2024 | 33,012.00 |
| Sep 30, 2024 | 117,044.00 |
| Jun 30, 2024 | 111,075.00 |
| Mar 31, 2024 | 69,924.00 |
| Dec 31, 2023 | 148,377.00 |
| Sep 30, 2023 | 69,990.00 |
| Jun 30, 2023 | 47,360.00 |
| Mar 31, 2023 | 24,173.00 |
| Dec 31, 2022 | 115,726.00 |
| Sep 30, 2022 | 32,846.00 |
| Jun 30, 2022 | 119,916.00 |
| Mar 31, 2022 | 11.25 Mn |
| Mar 31, 2021 | -55,229.00 |